Literature DB >> 27373619

Infection and Alcoholic Liver Disease.

Christine Chan1, Josh Levitsky2.   

Abstract

Acute and chronic alcohol use leads to an impaired immune response and dysregulated inflammatory state that contributes to a markedly increased risk of infection. Via shared mechanisms of immune-mediated injury, alcohol can alter the clinical course of viral infections such as hepatitis B, hepatitis C, and human immunodeficiency virus. These effects are most evident in patients with alcoholic hepatitis and cirrhosis. This article provides an overview of alcohol's effect on the immune system and contribution to the risks and outcomes of specific infectious diseases.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholic hepatitis; Cellular immunity; Cirrhosis; Infectious disease

Mesh:

Substances:

Year:  2016        PMID: 27373619     DOI: 10.1016/j.cld.2016.02.014

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  15 in total

1.  Native valve endocarditis, fusarium and end-stage renal disease.

Authors:  Supradip Ghosh; Atul Phillips; Sonali Ghosh; Amandeep Singh
Journal:  BMJ Case Rep       Date:  2018-04-05

Review 2.  Biogenesis, physiological functions and potential applications of extracellular vesicles in substance use disorders.

Authors:  Ernest T Chivero; Raghubendra Singh Dagur; Eric S Peeples; Susmita Sil; Ke Liao; Rong Ma; Liang Chen; Channabasavaiah B Gurumurthy; Shilpa Buch; Guoku Hu
Journal:  Cell Mol Life Sci       Date:  2021-04-05       Impact factor: 9.261

3.  Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: A prospective observational study.

Authors:  Wei Li; Tohti Amet; Yanyan Xing; Dennis Yang; Suthat Liangpunsakul; Puneet Puri; Patrick S Kamath; Arun J Sanyal; Vijay H Shah; Barry P Katz; Svetlana Radaeva; David W Crabb; Naga Chalasani; Qigui Yu
Journal:  Hepatology       Date:  2017-06-30       Impact factor: 17.425

Review 4.  Extracellular Vesicles: Intercellular Mediators in Alcohol-Induced Pathologies.

Authors:  Mohammad A Rahman; Benjamin J Patters; Sunitha Kodidela; Santosh Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-06       Impact factor: 4.147

5.  Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosis.

Authors:  Sakkarin Chirapongsathorn; Chayakrit Krittanawong; Felicity T Enders; Richard Pendegraft; Kristin C Mara; Bijan J Borah; Sue L Visscher; Conor G Loftus; Vijay H Shah; Jayant A Talwalkar; Patrick S Kamath
Journal:  Hepatol Commun       Date:  2018-01-18

6.  Age-related differences in clinical characteristics of invasive group G streptococcal infection: Comparison with group A and group B streptococcal infections.

Authors:  Yoshihiro Fujiya; Kayoko Hayakawa; Yoshiaki Gu; Kei Yamamoto; Momoko Mawatari; Satoshi Kutsuna; Nozomi Takeshita; Yasuyuki Kato; Shuzo Kanagawa; Norio Ohmagari
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

7.  Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic Hepatitis.

Authors:  Wei Li; Edward L Lin; Suthat Liangpunsakul; Jie Lan; Sai Chalasani; Sushmita Rane; Puneet Puri; Patrick S Kamath; Arun J Sanyal; Vijay H Shah; Svetlana Radaeva; David W Crabb; Naga Chalasani; Qigui Yu
Journal:  Clin Transl Gastroenterol       Date:  2019-06       Impact factor: 4.488

8.  Alcohol and COVID-19.

Authors:  Jonathan Chick
Journal:  Alcohol Alcohol       Date:  2020-06-25       Impact factor: 2.826

9.  Seroepidemiology of Toxoplasma gondii infection in people with alcohol consumption in Durango, Mexico.

Authors:  Sergio Estrada-Martinez; Alma Rosa Pérez-Álamos; Melina Ibarra-Segovia; Isabel Beristaín-Garcia; Agar Ramos-Nevárez; Leandro Saenz-Soto; Elizabeth Rábago-Sánchez; Carlos Alberto Guido-Arreola; Cosme Alvarado-Esquivel
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

10.  Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study.

Authors:  Donghee Kim; Nia Adeniji; Nyann Latt; Sonal Kumar; Patricia P Bloom; Elizabeth S Aby; Ponni Perumalswami; Marina Roytman; Michael Li; Alexander S Vogel; Andreea M Catana; Kara Wegermann; Rotonya M Carr; Costica Aloman; Vincent L Chen; Atoosa Rabiee; Brett Sadowski; Veronica Nguyen; Winston Dunn; Kenneth D Chavin; Kali Zhou; Blanca Lizaola-Mayo; Akshata Moghe; José Debes; Tzu-Hao Lee; Andrea D Branch; Kathleen Viveiros; Walter Chan; David M Chascsa; Paul Kwo; Renumathy Dhanasekaran
Journal:  Clin Gastroenterol Hepatol       Date:  2020-09-17       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.